Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

NCT01295593 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: valproic acid and 2-chlorodeoxyadenosine

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain